Top Markets
Coin of the day
LungLife AI, Inc. LungLife AI, Inc.

LungLife AI, Inc.

LLAI
Classement en actions #41523
LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating... LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating AI-powered solutions for detecting lung cancer. The company is actively developing LungLB, an advanced blood-based test that harnesses artificial intelligence and machine learning. LungLB is designed to precisely identify and quantify circulating tumor cells (CTCs), ultimately aiming to minimize manual intervention and elevate diagnostic performance. The organization, which was previously known as Cynvenio Biosystems, Inc., adopted the LungLife AI, Inc. moniker in May of 2019. Its operations are based in Thousand Oaks, California.
Prix de l'action
$0.05646911
Dernière synchronisation: 2025-05-28
Capitalisation boursière
$17.31K
Changement (1 jour)
-1.67%
Changement (1 an)
0.00%
Pays
US
Échange LungLife AI, Inc. (LLAI)

Catégorie

Ratio P/B pour LungLife AI, Inc. (LLAI)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de LungLife AI, Inc., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour LungLife AI, Inc. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
4.0441 -
US
2.6166 -
US
- -
CN
28.7765 -
US
21.3575 -
US